These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1149303)

  • 21. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
    Bercu BB; Root AW; Shulman DI
    J Clin Endocrinol Metab; 1986 Oct; 63(4):968-73. PubMed ID: 3018032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A low response of pituitary growth hormone secretion in the patient with diabetes mellitus after intravenous administration of L-dopa (author's transl)].
    Shimoda S; Takemura Y; Ieiri T; Kasai K; Kikuchi T
    Nihon Naibunpi Gakkai Zasshi; 1975 Jan; 51(1):9-17. PubMed ID: 1171032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone response to low-dose apomorphine in restless legs syndrome.
    Happe S; Bachmann CG; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
    Growth Horm IGF Res; 2007 Aug; 17(4):323-7. PubMed ID: 17512770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum growth hormone levels in Hunter's syndrome].
    Toledo SP; Costa VH; Fukui RR; Abelin N
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(1):9-13. PubMed ID: 1843006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aminergic and thermoregulatory mechanims in hypothalamic regulation of growth hormone in cats.
    Ruch W; Mixter RC; Russell RM; Garcia JF; Gale CC
    Am J Physiol; 1977 Jul; 233(1):E61-9. PubMed ID: 301705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blindness impairs plasma growth hormone response to L-dopa but not to arginine.
    Bellastella A; Parlato F; Sinisi AA
    J Clin Endocrinol Metab; 1990 Apr; 70(4):856-8. PubMed ID: 2318945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of impaired growth hormone secretion in patients with Cushing's disease.
    Takahashi H; Bando H; Zhang C; Yamasaki R; Saito S
    Acta Endocrinol (Copenh); 1992 Jul; 127(1):13-7. PubMed ID: 1519417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone (GH) responses to arginine and L-dopa alone and after GHRH pretreatment.
    Page MD; Dieguez C; Valcavi R; Edwards C; Hall R; Scanlon MF
    Clin Endocrinol (Oxf); 1988 May; 28(5):551-8. PubMed ID: 3145820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of domperidone on apomorphine-induced growth hormone secretion in normal men.
    Lal S; Nair NP; Iskandar HL; Etienne P; Wood PL; Schwartz G; Guyda H
    J Neural Transm; 1982; 54(1-2):75-84. PubMed ID: 7108512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
    Hanew K; Aida M; Tano T; Yoshinaga K
    Tohoku J Exp Med; 1977 Mar; 121(3):197-206. PubMed ID: 404727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
    Hietala J; Koulu M; Scheinin M; Syvälahti E
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):451-4. PubMed ID: 3935892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth-hormone and somatostatin effects on [75Se]selenomethionine uptake by the pancreas.
    Atkins HL; Som P
    J Nucl Med; 1979 Jun; 20(6):543-6. PubMed ID: 536826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectof sex, oral contraceptives, and glucose loading on apomorphine-induced growth hormone secretion.
    Ettigi P; Lal S; Martin JB; Friesen HG
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1094-8. PubMed ID: 1133158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone in exercise: comparison of physiological and pharmacological stimuli.
    Sutton J; Lazarus L
    J Appl Physiol; 1976 Oct; 41(4):523-7. PubMed ID: 985395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects.
    Hanew K; Tanaka A; Utsumi A; Sugawara A; Abe K
    J Clin Endocrinol Metab; 1996 May; 81(5):1952-5. PubMed ID: 8626863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.
    Aloi JA; Gertz BJ; Hartman ML; Huhn WC; Pezzoli SS; Wittreich JM; Krupa DA; Thorner MO
    J Clin Endocrinol Metab; 1994 Oct; 79(4):943-9. PubMed ID: 7962302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-Dopa stimulated growth hormone release in the blind.
    Bellastella A; Colucci CF; D'Alessandro B; Lo Cicero M
    J Clin Endocrinol Metab; 1977 Jan; 44(1):194-5. PubMed ID: 833257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
    Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H
    J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotransmitter regulation of growth hormone and ACTH in the rhesus monkey: effects of biogenic amines.
    Chambers JW; Brown GM
    Endocrinology; 1976 Feb; 98(2):420-8. PubMed ID: 2458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the effect of levodopa and somatostatin on the plasma levels of growth hormone, insulin, glucagon and prolactin in acromegaly.
    Dunn PJ; Donald RA; Espiner EA
    Clin Endocrinol (Oxf); 1976 Mar; 5(2):167-74. PubMed ID: 1269163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.